We are live on
!
Find out more
GCGM
General Catalyst Group Management Portfolio holdings
AUM
$184M
1-Year Est. Return
50.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.68%
1 Year Est. Return
+50.45%
3 Year Est. Return
+205.57%
5 Year Est. Return
+78.87%
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$27M
(+2.1%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-8.01%
Top 10 Holdings %
Top 10 Hldgs %
99.98%
Holding
11
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ArriVent BioPharma
AVBP
|
+$30.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$134M |
| 2 |
Vroom Inc
VRM
|
+$20 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 82.32% |
| 2 | Healthcare | 10.39% |
| 3 | Industrials | 3.7% |
| 4 | Consumer Discretionary | 3.55% |
| 5 | Financials | 0.04% |
Similar funds
IFPL
MIM
EFIC
SWMG
AAM
RFG
KWM
NAM
General Catalyst Group Management's Q1 2024 Portfolio in Review
As of Q1 2024, General Catalyst Group Management held 11 positions worth $1.3B, up 2.1% from $1.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
General Catalyst Group Management withdrew a net $104M in Q1 2024, reducing 2 holdings. Its largest reduction was Samsara, cutting an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 82% of assets, down from 86% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, General Catalyst Group Management opened a new position in ArriVent BioPharma worth $26.7M.
- General Catalyst Group Management's largest Q1 2024 buy was ArriVent BioPharma: 1,494,786 shares worth $26.7M.
- General Catalyst Group Management's biggest Q1 2024 reduction was Samsara, cutting an estimated $134M.
- General Catalyst Group Management's ten largest holdings make up 100% of its $1.3B portfolio in Q1 2024.
- General Catalyst Group Management opened 1 new position and closed 0 in Q1 2024.
- General Catalyst Group Management's portfolio value rose 2.1% quarter-over-quarter to $1.3B.
Based on General Catalyst Group Management's 13F filing for Q1 2024, filed 10 May 2024.